Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Pediatr Blood Cancer. 2014 Jun 17;61(10):1798–1805. doi: 10.1002/pbc.25108

TABLE III.

Antiemetic Switch and Rescue During and Across Treatment Cycles

Antiemetic Switch Antiemetic Rescue
OR (95% C.I.) p-value IRR (95% C.I.) p-value
Subsequent Days Within a Cycle Consecutive Days on Chemotherapy 0.91 (0.84–0.98) 0.009 0.99 (0.98–0.99) 0.009
Consecutive Days after Chemotherapy 0.96 (0.93–0.98) 0.002 1.008 (1.005–1.01) <0.001
In Subsequent Cycles: Days on Chemotherapy 1 Referent Referent
2 0.56 (0.37–0.83) 0.004 0.89 (0.83–0.96) 0.002
3 0.54 (0.34–0.86) 0.01 0.92 (0.84–1.01) 0.088
4 0.27 (0.12–0.55) <0.001 0.81 (0.73–0.90) <0.001
5 0.29 (0.13–0.62) 0.001 0.77 (0.68–0.86) <0.001
In Subsequent Cycles: Days after Chemotherapy (Non-chemo) 1 Referent Referent
2 0.70 (0.42–1.16) 0.165 0.95 (0.83–1.08) 0.431
3 0.99 (0.63–1.57) 0.971 1.06 (0.94–1.19) 0.329
4 0.70 (0.42–1.19) 0.188 1.14 (0.99–1.30) 0.051
5 0.42 (0.18–1.00) 0.051 0.97 (0.81–1.16) 0.713
Prior antiemetic switch 1.39 (1.21–1.59) <0.001